- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03103126
HOme-Based Exercise for Patients With Type 2 Diabetes (HOtBED)
The Effects of HOme-Based Combined Exercise on Glycaemic Control and Anthropometric Measurements in Patients With Type 2 Diabetes
The study aims to investigate whether 12 weeks of structured aerobic and resistance exercises completed at home can have a beneficial effect on the health of patients with type 2 diabetes compared to standard physical activity advice. The study will investigate whether the exercises can reduce factors such as patient's BMI, blood pressure and waist circumference, as well as blood glucose and insulin sensitivity. Participants will use pedometers and Therabands to carry out their exercises.
This will be compared to giving participants a physical activity advice sheet and no structured exercise examples.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be a 12 week randomised controlled trial, so that the researchers can isolate the independent variable of home-based combined exercise to ensure that factor is affecting the patient's measurements. Participants will be recruited from a DESMOND day through the medical team informing them of the study via a Participant Information Sheet. Once recruited and informed consent is obtained, the participants will be assigned an ID number so that they can remain anonymous, and then will be randomly allocated into either the exercise or control group. Ideally 9 participants will be recruited into each group.
All participants will be invited into the Spinnaker Physiology Laboratory at Portsmouth University at a specified date. They will have their health and fitness data collected and complete a 7-day physical activity recall questionnaire, SF-36 Form and Self-Efficacy Questionnaire before and after the intervention period to measure any change in their PA levels, self-perceived health status and self-efficacy towards exercise. They will be provided with a 7 day food diary to complete.
A control group is included so that the researchers can rule out other factors that may affect glycaemic control and anthropometric measurements. The control group will be given a Physical Activity Advice sheets as this mimics what they would normally have access to through DESMOND. The control group will receive a Physical Activity advice sheet and the researchers will talk through the advice sheet with the participants. If the control group were to have no intervention, this would be less than they normally have access to as part of their normal diabetes treatment.
The exercise group will be given the therabands and pedometer, a Physical Activity Log, Pedometer log, theraband protocol and Physical Activity Advice sheet, which will all be explained to the participant. All theraband exercises will be performed so that the researchers can ensure the participant has a good technique. The exercise intervention resistance segment will involve the exercise group performing 7 theraband exercises on three days per week on non-consecutive days. For the aerobic exercise, the participants will be asked to use the provided pedometer to record the number of steps they complete on day 1 of the intervention (assuming that on this day, they complete their normal daily activities that they would do most days of the week). They then are asked to add 2,000 steps onto their daily steps; this amount will then become their daily step goal. Once they have reached this goal on 4 out of 5 days, they are asked to increase their step goal by 500.
The participants will be invited back after 12 weeks to repeat the pre-study measures to assess any changes.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hampshire
-
Portsmouth, Hampshire, United Kingdom, PO1 2ER
- Andrew Scott
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants must not be meeting the government's recommended physical activity guideline (150 min moderate intensity exercise per week)
- Must be 18 years of age or over
- Diagnosed with Type 2 Diabetes and have been referred to DESMOND, as this is where they will be recruited from.
Exclusion Criteria:
● Co-morbidity that prevents them undertaking physical activity safely, such as cardiac disease or pulmonary disease or significant musculoskeletal limitations. This will be determined from the Exercise and Health History Questionnaire. If their diabetes is severe and they have peripheral neuropathy or any associated systemic, cardiovascular, metabolic or musculoskeletal problems which will inhibit their ability to perform exercise safely.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Standard care.
|
|
|
Experimental: Combined resistance exercise and walking
Combined resistance exercise and walking.
|
Combined resistance exercise and walking
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effects of home-based combined exercise on insulin sensitivity compared to physical activity advice during the 6 week study period
Time Frame: 6 weeks
|
Insulin sensitivity will be calculated from plasma glucose and serum insulin measures
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effects of HBCE on body mass index (BMI) compared to physical activity advice during the 6 week study period
Time Frame: 6 weeks
|
Height and body mass will be measured to determine whether the intervention improves BMI (kg.m2)
|
6 weeks
|
|
The effects of HBCE on waist circumference compared to physical activity advice during the 6 week study period
Time Frame: 6 weeks
|
To determine whether the intervention improves waist circumference in centimetres
|
6 weeks
|
|
The effects of HBCE on body fat percentage compared to physical activity advice during the 6 week study period
Time Frame: 6 weeks
|
To determine whether the intervention improves body fat percentage using bioelectrical impedance analysis
|
6 weeks
|
|
The effect of HBCE on physical activity levels compared to physical activity advice during the 6 week study period
Time Frame: 6 weeks
|
To determine if HBCE is more effective at increasing physical activity compared to physical activity advice using an International Physical Activity Questionnaire at baseline and the last week of the study period.
|
6 weeks
|
|
The effect of HBCE on fitness compared to physical activity advice during the 6 week study period
Time Frame: 6 weeks
|
To determine if HBCE is more effective at increasing fitness levels compared to physical activity advice using the Tecumseh step test, a modified version of the Harvard step test (Shorter test period and shorter step).
|
6 weeks
|
|
The number of participants recruited and the average number per week
Time Frame: 6 weeks
|
Can sufficient participant numbers can be recruited from a DESMOND day?
The number of participants recruited and average per week of recruitment will be recorded and calculated.
|
6 weeks
|
|
The percentage adherence to the home-based combined exercise programme
Time Frame: 6 weeks
|
Adherence to the home-based combined exercise programme will be monitored in a diary
|
6 weeks
|
|
Self-perceived health status measured using the SF-36 quality of life scale
Time Frame: 6 weeks
|
The SF36 will be applied at baseline and post-intervention in both groups to determine any changes and differences between control vs exercise groups
|
6 weeks
|
|
Self-efficacy to regulate exercise scale
Time Frame: 6 weeks
|
The self-efficacy to regulate exercise scale will be applied at baseline and post-intervention in both groups to determine any changes and differences between control vs exercise groups
|
6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Andrew T Scott, PhD, University of Portsmouth
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HOtBED
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
Canterbury Christ Church UniversityBarts & The London NHS Trust; Betsi Cadwaladr University Health BoardRecruitingType 1 Diabetes Mellitus | Type 2 Diabetes Mellitus (T2DM)United Kingdom
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
Clinical Trials on Combined resistance exercise and walking
-
Beijing Sport UniversityRecruitingHypertension | Cognitive FunctionChina
-
Taipei Medical UniversityRecruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension | Healthy
-
University of RochesterCompleted
-
Iowa State UniversityCompletedCardiovascular Risk Factor
-
Federal University of São PauloUniversity of Santo AmaroUnknown
-
University of OklahomaNational Institute on Aging (NIA); Oklahoma Center for the Advancement of Science...CompletedIntermittent ClaudicationUnited States
-
National Institute of Nursing Research (NINR)CompletedSleep | Dementia | ElderlyUnited States
-
Riphah International UniversityNot yet recruiting
-
The University of Texas Health Science Center at...National Institute on Aging (NIA)RecruitingRehabilitation | Atrophy of Muscle Due to DisuseUnited States